Sfoglia per Titolo
Oxaliplatin induced Peripheral Neurotoxicity (OIPN): a Rat Model that full encompasses all OIPN Phenomena
2018 Alberti, P; Fumagalli, G; Monza, L; Pozzi, E; Chiorazzi, A; Canta, A; Oggioni, N; Marmiroli, P; Cavaletti, G
Oxaliplatin induced peripheral neurotoxicity (OIPN): a translational approach for drug discovery.
2020 Alberti, P; Ballarini, E; Canta, A; Chiorazzi, A; Fumagalli, G; Malacrida, A; Meregalli, C; Monza, L; Pozzi, E; Marmiroli, P; Cavaletti, G
Oxaliplatin induced peripheral neurotoxicity – a neurophysiological translational approach
2016 Alberti, P; Fumagalli, G; Cavaletti, G; Ferrarese, C; Appollonio, I
Oxaliplatin Induced Peripheral Neurotoxicity: From Bed to Bench Side and Vice Versa
2023 Alberti, P
Oxaliplatin induced peripheral neurotoxicity: nerve excitability testing full profile in a long term toxicity animal study
2017 Alberti, P; Fumagalli, G; Monza, L; Pozzi, E; Canta, A; Chiorazzi, A; Cavaletti, G
Oxaliplatin Induced Peripheral Neurotoxicity: what we know and what we need
2016 Alberti, P
Oxaliplatin induces pH acidification in dorsal root ganglia neurons
2018 Riva, B; Dionisi, M; Potenzieri, A; Chiorazzi, A; Cordero-Sanchez, C; Rigolio, R; Carozzi, V; Lim, D; Cavaletti, G; Marmiroli, P; Distasi, C; Genazzani, A
Oxaliplatin Neurotoxicity is related to SLC4A1 Expression in BALB/c Mice Dorsal Root Ganglia
2016 Ballarini, E; Pozzi, E; Riva, B; Genazzani, A; Cavaletti, G; Marmiroli, P; Carozzi, V
Oxaliplatin neurotoxicity: morpho-functional approach
2023 Alberti, P; Pozzi, E; Serra, M; Trucas, M; Boi, M; Capelli, C; Invernizzi, C; Rodriguez-Menendez, V; Quartu, M; Cavaletti, G
Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial
2021 Rosati, G; Lonardi, S; Galli, F; Di Bartolomeo, M; Ronzoni, M; Zampino, M; Banzi, M; Zaniboni, A; Pasini, F; Bozzarelli, S; Garattini, S; Ferrari, D; Montesarchio, V; Mambrini, A; Ciuffreda, L; Galli, F; Pusceddu, V; Carlomagno, C; Bidoli, P; Amoroso, D; Bochicchio, A; Frassineti, L; Corsi, D; Bilancia, D; Pastorino, A; De Stefano, A; Labianca, R; Bilancia, D; Rosati, G; Montesarchio, V; Iaffaioli, R; Nasti, G; Daniele, B; Zagonel, V; Pella, N; Aprile, G; Pasini, F; Marchetti, R; Romiti, A; Ferrari, D; Foa, P; Zaniboni, A; Mosconi, S; Sobrero, A; Bidoli, P; Cazzaniga, M; Beretta, G; Cortesi, E; Barni, S; Petrelli, F; Allione, P; D'Arco, A; Valmadre, G; Piazza, E; Veltri, E; Ramus, G; Giustini, L; Tumulo, S; Cascinu, S; Granetto, C; Testore, F; Giordano, M; Moroni, M; Di Seri, M; Nuzzo, A; Angelelli, L; Gori, S; Farina, G; Aglietta, M; Franchi, R; Comande, M; Giordani, P; Tonini, G; Bucci, E; Ballestrero, A; Benasso, M; Graiff, C; Bravi, S; Caffo, O; Silva, R; Frontini, L; Rota, S; Cozzi, L; Cantore, M; Maiello, E; Cinieri, S; Silvestris, N; Romito, S; Gebbia, V; Banzi, M; Santoro, A; Artioli, F; Mattioli, R; Contu, A; Di Costanzo, F; Leonardi, F; Cavanna, L; Passalacqua, R; Amoroso, D; Sozzi, P; D'Amico, M; Amadori, D; Frassineti, L; Turci, D; Ravaioli, A; Pasquini, E; Gambi, A; Faedi, M; Cruciani, G; Bajetta, E; Di Bartolomeo, M; Gianni, L; Ionta, M; Massidda, B; Scartozzi, M; Zampino, M; Bochicchio, A; Ciarlo, A; Di Leo, A; Frustaci, S; Rangoni, G; Arizzoia, A; Pavesi, L; Verusio, C; Pinotti, G; Iop, A; De Placido, S; Carlomagno, C; Adamo, V; Ficorella, C; Natale, D; Greco, E; Rulli, E; Galli, F; Poli, D; Porcu, L; Torri, V
Oxaliplatin toxicity in dorsal root ganglia explants and neuron dissociated cultures
2003 Scuteri, A; Nicolini, G; Donzelli, E; Bossi, M; Miloso, M; Cavaletti, G; Tredici, G
Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial
2014 Taieb, J; Tabernero, J; Mini, E; Subtil, F; Folprecht, G; Van Laethem, J; Thaler, J; Bridgewater, J; Petersen, L; Blons, H; Collette, L; Van Cutsem, E; Rougier, P; Salazar, R; Bedenne, L; Emile, J; Laurent-Puig, P; Lepage, C; Bidoli, P
Oxaliplatin-induced neuropathy occurs through impairment of haemoglobin proton buffering and is reversed by carbonic anhydrase inhibitors
2020 Potenzieri, A; Riva, B; Rigolio, R; Chiorazzi, A; Pozzi, E; Ballarini, E; Cavaletti, G; Genazzani, A
Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2
2013 Sprowl, J; Ciarimboli, G; Lancaster, C; Giovinazzo, H; Gibson, A; Du, G; Janke, L; Cavaletti, G; Shields, A; Sparreboom, A
Oxaliplatin-Induced Peripheral Neuropathy and Identification of Unique Severity Groups in Colorectal Cancer
2017 Griffith, K; Zhu, S; Johantgen, M; Kessler, M; Renn, C; Beutler, A; Kanwar, R; Ambulos, N; Cavaletti, G; Bruna, J; Briani, C; Argyriou, A; Kalofonos, H; Yerges-Armstrong, L; Dorsey, S
OXALIPLATIN-INDUCED PERIPHERAL NEUROTOXICITY IN MOUSE MODELS: DIFFERENT TREATMENT SCHEDULES AND FOCUS ON OXIDATIVE STRESS
2020 Pozzi, E
Oxaliplatin-Induced Peripheral Neurotoxicity: a Role for Genomics?
2015 Marmiroli, P; Pozzi, E; Riva, B; Lim, D; Genazzani, A; Cavaletti, G; Renn, C; Dorsey, S; Carozzi, V
Oxaliplatin-Induced Peripheral Neurotoxicity: Morphological Characterization In Different Mouse Strains
2015 Carozzi, V; Pozzi, E; Chiorazzi, A; Meregalli, C; Oggioni, N; Ballarini, E; Canta, A; Avezza, F; Renn, C; Dorsey, S; Cavaletti, G; Marmiroli, P
Oxazole-based compounds as anticancer agents
2019 Chiacchio, M; Lanza, G; Chiacchio, U; Giofre, S; Romeo, R; Iannazzo, D; Legnani, L
Oxcarbazepine free or loaded PLGA nanoparticles as effective intranasal approach to control epileptic seizures in rodents
2018 Musumeci, T; Serapide, M; Pellitteri, R; Dalpiaz, A; Ferraro, L; Dal Magro, R; Bonaccorso, A; Carbone, C; Veiga, F; Sancini, G; Puglisi, G
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile